Citation: Asm. Harada et Mb. Nichol, PREDICTING THE PROBABILITY OF ACHIEVING NCEP LDL-C TREATMENT GOALS USING HMG-COA REDUCTASE INHIBITOR MONOTHERAPY, American journal of managed care, 4(8), 1998, pp. 425-435
Authors:
SUNG JCY
NICHOL MB
VENTURINI F
BAILEY KL
MCCOMBS JS
CODY M
Citation: Jcy. Sung et al., FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION, American journal of managed care, 4(10), 1998, pp. 1421-1430
Authors:
SUNG JCY
NICHOL MB
VENTURINI F
BAILEY KL
MCCOMBS JS
CODY M
Citation: Jcy. Sung et al., FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION, American journal of managed care, 3(10), 1997, pp. 16-16
Authors:
NICHOL MB
MARGOLIES JE
LIPPA E
ROWE M
QUELL J
Citation: Mb. Nichol et al., THE APPLICATION OF MULTIPLE QUALITY-OF-LIFE INSTRUMENTS IN INDIVIDUALS WITH MILD-TO-MODERATE PSORIASIS, PharmacoEconomics, 10(6), 1996, pp. 644-653
Citation: Js. Mccombs et Mb. Nichol, THE USE OF FIRST-LINE AND 2ND-LINE OUTPATIENT ANTIBIOTICS UNDER THE SASKATCHEWAN DRUG PLAN, PharmacoEconomics, 7(6), 1995, pp. 543-554
Citation: Mb. Nichol et al., FACTORS PREDICTING THE USE OF MULTIPLE PSYCHOTROPIC MEDICATIONS, The Journal of clinical psychiatry, 56(2), 1995, pp. 60-66
Authors:
MCCOMBS JS
CODY M
BESINQUE K
BOROK G
ERSHOFF D
GROSHEN S
HAY J
JOHNSON KA
NICHOL MB
NYE MT
Citation: Js. Mccombs et al., MEASURING THE IMPACT OF PATIENT COUNSELING IN THE OUTPATIENT PHARMACYSETTING - THE RESEARCH DESIGN OF THE KAISER-PERMANENTE USC PATIENT CONSULTATION STUDY, Clinical therapeutics, 17(6), 1995, pp. 1188-1206